Strong activation domain
AssigneeMendel Biotechnology, Inc.
InventorsRoger Canales, Shiv Tiwari, T. Lynne Reuber, Karen S. Century, Oliver J. Ratcliffe
Life of this patent
Estimating the term…
Loading patent…
AssigneeMendel Biotechnology, Inc.
InventorsRoger Canales, Shiv Tiwari, T. Lynne Reuber, Karen S. Century, Oliver J. Ratcliffe
Estimating the term…
A new and strong transcriptional activation domain was identified from the Arabidopsis protein Ethylene Response Factor 98 (AtERF98). This domain has been designated as the “EDLL domain” and has a number of highly conserved amino acid residues that are found throughout the members of the AtERF98 family from plants, including in monocot and eudicot orthologs. The EDLL domain was shown to be highly active when it was fused to transcription factors from plant and yeast, and was also shown to have activation potential comparable to the widely-used VP16 activation domain derived from Herpes simplex. The EDLL domain was also active when it was targeted to a gene promoter by a sequence-specific DNA binding protein or by protein-protein interactions. Unlike other known activation domains such as VP16 and GAL4, the EDLL domain is relatively small in size, and being of plant origin, it is favored as a strong transcriptional activation tool for application in transgenic food crops.
A synthetic chimeric polypeptide comprising a transcription activation domain of:
A host plant cell comprising a nucleic acid construct encoding a chimeric polypeptide comprising a transcription activation domain covalently fused to a transcription regulatory polypeptide, wherein the transcription activation domain and the transcription regulatory polypeptide are mutually heterologous and do not occur in nature in the same protein, or do not occur in the same copy number or configuration in nature;
A method for increasing the expression of a target polynucleotide sequence, the methods steps comprising:
Dependencies are inferred from the claim text.